Proximity to nuclear power plants was associated with higher cancer mortality rates across multiple age groups and genders.

Monthly costs for Ozempic and Wegovy will decrease to $675 in 2027, matching price adjustments scheduled for federal Medicare programs.

Disparities in diagnosis and access to care were more significant in AI/AN patients than in White patients with malignant melanoma.

Delayed full-thickness skin grafting after skin cancer resection was associated with a higher rate of graft success than immediate skin grafting.

Medicare hospice discharges after ICU admission increased significantly between 2011 and 2023, reflecting a shift in care priorities.

Adult patients with cancer who developed a new mental health disorder within 1 year of diagnosis had a significantly higher risk for death.

Menopausal hormone therapy was not associated with an increased risk for mortality in a large nationwide cohort of Danish women followed for 14 years.

Clinical data show remibrutinib treatment leads to significant reductions in urticaria activity scores compared with placebo within the first week.

The FDA proposed new guidelines for approving experimental therapies for rare diseases without large group studies.

Bypassing the nearest surgical hospital for urgent abdominal surgery was associated with increased disease progression and complications.

The Trump administration proposed ACA rules to lower premiums by increasing out-of-pocket costs and high deductibles.

The ACIP was scheduled to discuss COVID-19 vaccine injuries at a March meeting, potentially voting on future immunization recommendations.